Clinical trial
The Effects of Trimetazidine on Diabetic Nephropathy
NCT05147194 is registered in ClinicalTrials.gov with Tongji Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effects of Trimetazidine on Diabetic Nephropathy
- Lead sponsor
- Tongji Hospital
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- January 1, 2022
- Completion date
- December 31, 2023
- Enrollment
- 150 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.